Related Experiment Video
Updated: May 14, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Specialty pharmacy: will the promise deliver?
Biotechnology Healthcare
|February 21, 2013
Summary
Specialty pharmacy faces challenges with complex biologics requiring expert services. Current models may not meet the demands of new therapies and health plan expectations for value.
Area of Science:
- Pharmaceutical Sciences
- Health Services Research
Background:
- Traditional specialty pharmacy effectively managed prepackaged medications.
- Emerging biologics necessitate advanced clinical expertise and intensive patient support.
- Increasingly complex drug therapies are straining existing specialty pharmacy service models.
Purpose of the Study:
- To evaluate the capacity of current specialty pharmacy models to handle new, complex biologic medications.
- To address health plan concerns regarding the value and cost-effectiveness of specialty pharmacy services for advanced therapies.
Main Methods:
- Analysis of service requirements for novel biologics.
- Assessment of current specialty pharmacy capabilities and resource allocation.
- Review of health plan perspectives on specialty pharmacy value proposition.
Main Results:
- Newer biologics demand significant professional expertise, intensive patient services, and higher operational costs.
- Existing specialty pharmacy infrastructure may be insufficient to meet these evolving demands.
- Health plans are actively scrutinizing the economic viability and service delivery of the current specialty pharmacy model.
Conclusions:
- Specialty pharmacy must adapt its service offerings and operational models to effectively manage complex biologics.
- Further innovation and investment are required to ensure specialty pharmacy can meet future therapeutic and stakeholder needs.
- The value proposition of specialty pharmacy is under review, necessitating a strategic re-evaluation of service delivery and cost structures.
More Related Videos
Related Concept Videos
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...